Medidata Solutions Inc (MDSO) Forecasted to Earn Q1 2018 Earnings of $0.17 Per Share

Medidata Solutions Inc (NASDAQ:MDSO) – Analysts at Dougherty & Co issued their Q1 2018 earnings estimates for Medidata Solutions in a note issued to investors on Monday. Dougherty & Co analyst G. Mannheimer forecasts that the company will earn $0.17 per share for the quarter. Dougherty & Co has a “Buy” rating and a $75.00 price target on the stock.

A number of other brokerages have also weighed in on MDSO. Royal Bank of Canada restated a “hold” rating and issued a $80.00 price objective on shares of Medidata Solutions in a report on Friday, October 27th. Zacks Investment Research lowered Medidata Solutions from a “hold” rating to a “sell” rating in a report on Wednesday, December 27th. BidaskClub upgraded Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. Needham & Company LLC decreased their price objective on Medidata Solutions to $75.00 and set a “buy” rating on the stock in a report on Friday. Finally, Morgan Stanley decreased their price objective on Medidata Solutions from $86.00 to $79.00 and set an “overweight” rating on the stock in a report on Friday. One analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have given a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $83.00.

Medidata Solutions (NASDAQ:MDSO) opened at $62.48 on Tuesday. Medidata Solutions has a 52-week low of $54.36 and a 52-week high of $85.92. The stock has a market capitalization of $3,807.70, a P/E ratio of 84.43, a PEG ratio of 3.49 and a beta of 1.58. The company has a debt-to-equity ratio of 0.20, a quick ratio of 3.37 and a current ratio of 1.50.

Medidata Solutions (NASDAQ:MDSO) last announced its earnings results on Thursday, February 8th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. Medidata Solutions had a return on equity of 11.59% and a net margin of 8.14%. The firm had revenue of $141.20 million for the quarter, compared to analyst estimates of $140.65 million. During the same quarter last year, the firm posted $0.33 EPS. The business’s revenue was up 13.4% on a year-over-year basis.

Several institutional investors and hedge funds have recently modified their holdings of the business. Champlain Investment Partners LLC increased its stake in shares of Medidata Solutions by 9.6% in the 4th quarter. Champlain Investment Partners LLC now owns 1,856,985 shares of the company’s stock worth $117,677,000 after acquiring an additional 163,045 shares during the last quarter. ARK Investment Management LLC increased its stake in shares of Medidata Solutions by 212.7% in the 4th quarter. ARK Investment Management LLC now owns 326,079 shares of the company’s stock worth $20,664,000 after acquiring an additional 221,799 shares during the last quarter. Carillon Tower Advisers Inc. acquired a new stake in shares of Medidata Solutions in the 4th quarter worth $35,164,000. Quadrature Capital Ltd acquired a new stake in shares of Medidata Solutions in the 4th quarter worth $992,000. Finally, Brown Advisory Inc. increased its stake in shares of Medidata Solutions by 21.2% in the 4th quarter. Brown Advisory Inc. now owns 543,515 shares of the company’s stock worth $34,443,000 after acquiring an additional 95,146 shares during the last quarter. 97.52% of the stock is owned by institutional investors and hedge funds.

In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the firm’s stock in a transaction on Wednesday, November 15th. The stock was sold at an average price of $66.33, for a total value of $331,650.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Rouven Bergmann sold 2,000 shares of the firm’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $65.40, for a total value of $130,800.00. Following the completion of the sale, the chief financial officer now directly owns 91,775 shares of the company’s stock, valued at $6,002,085. The disclosure for this sale can be found here. Insiders sold a total of 29,010 shares of company stock valued at $1,962,206 over the last ninety days. Corporate insiders own 5.80% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Medidata Solutions Inc (MDSO) Forecasted to Earn Q1 2018 Earnings of $0.17 Per Share” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/13/medidata-solutions-inc-mdso-forecasted-to-earn-q1-2018-earnings-of-0-17-per-share.html.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply